Find new possibilities for your research with Finnish biobank data

Find suitable samples, data, study participants, and biobank cohorts for your project needs to set a new course for your research.

Explore now Register

Easy tools for browsing Finnish biobanks' sample and data collections

FINBB provides visibility to Finnish biobank data repositories' offerings and helps you to find samples, data, and patients for your research projects via Fingenious^® Availability services.

The Catalogue application brings biobank sample and data collections available for researchers. Researchers can search sample and data availability based on ICD-10 diagnosis codes. The Catalogue application is an online find and search tool for researchers that allows fast and easy browsing of sample collections at an aggregated summary level. It provides a complete overview of what biobanks have to offer.

Researchers can search and find Finnish biobanks' research cohorts in the new visual Cohorts application. Fingenious^® Cohorts represents wide-ranging sample collections and research cohorts that are available in Finnish public biobanks.

The cohorts are sets of samples or data which share a common characteristic. In addition to traditional research collections, cohorts can be built based on sample type, diagnosis, or they can even be a set of samples or data that are available through multiple biobanks for a specific research project.

Availability services:

Allow researchers easily search and find potential material for their research project before submitting official request for biobanks
Increase awareness of the variety of biobank samples and data richness
Raise possibilities for new types of research
Give ideas for new research

Recruit study participants

Feasibility requests

Contact us

We're ready to support you in your biomedical research efforts. Contact us now and we'll be in touch with you at the earliest opportunity.

Register with Fingenious Service

Sign up for Fingenious services and see what Finnish biobanks have to offer for biomedical research. It’s easy, quick, and you can get the whole service from one service provider.

News & Updates

Ecosystem

Combining data from different registries for research purposes in Finland - The lymphoma study combined data from six data controllers

Finland offers a unique and advantageous environment for conducting real-world evidence (RWE) studies. Data retrieved from the Finnish health and social care registries may be more representative compared to other countries. Therefore, Finland is a strong option when weighing in which country the research would be carried out in. This article by Medaffcon presents a multiregistry study combining health and social data.

Ecosystem

Post-licensure vaccine study expertise in Finland: case FVR

Fingenious® Ecosystem Partner, FVR – Finnish Vaccine Research Ltd., a special-assignment company of the Finnish state, conducts commercial vaccine studies in phases 1-4 with decades of experience and internationally recognized, high-quality scientific expertise. In addition to clinical vaccine trials, FVR has extensive experience in conducting phase 4 observational vaccine studies (RWE) and pragmatic clinical trials for evaluating vaccine effectiveness, safety, and disease burden. Explore FVR examples of post-licensure studies.

Use cases

T and B cell receptor repertoire in autoimmune diseases - a unique immunoSEQ® dataset available for researchers

In collaboration with FINBB, Adaptive Biotechnologies has been working with biobanks across Finland. The focus was on studying large number of blood samples to discover and validate TCR signatures specific to various autoimmune diseases. Working with FINBB through Fingenious® has allowed Adaptive to identify useful cohorts of patient samples. The Finnish homogenous population provides a unique opportunity to find different signals related to autoimmune diseases. Now the returned data for large-scale sequencing of T- and B-cell receptors is a valuable dataset for many researchers. It can be requested from Fingenious® for other studies.

See all news